X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PANACEA BIOTECH DR. DATSONS LABS/
PANACEA BIOTECH
 
P/E (TTM) x -10.9 84.6 - View Chart
P/BV x 0.2 1.9 8.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   PANACEA BIOTECH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PANACEA BIOTECH
Mar-14
DR. DATSONS LABS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs126149 84.5%   
Low Rs3182 37.5%   
Sales per share (Unadj.) Rs133.084.1 158.1%  
Earnings per share (Unadj.) Rs0.2-18.3 -0.8%  
Cash flow per share (Unadj.) Rs6.6-6.7 -98.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.883.7 153.9%  
Shares outstanding (eoy) m31.6661.25 51.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.4 42.9%   
Avg P/E ratio x516.1-6.3 -8,180.6%  
P/CF ratio (eoy) x11.8-17.2 -68.7%  
Price / Book Value ratio x0.61.4 44.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4777,074 35.0%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m561,449 3.9%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m4,2115,154 81.7%  
Other income Rs m79100 78.9%   
Total revenues Rs m4,2895,254 81.6%   
Gross profit Rs m569-766 -74.2%  
Depreciation Rs m204711 28.7%   
Interest Rs m4301,503 28.6%   
Profit before tax Rs m13-2,881 -0.4%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-6 31.6%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m617 36.3%   
Profit after tax Rs m5-1,121 -0.4%  
Gross profit margin %13.5-14.9 -90.8%  
Effective tax rate %48.0-0.6 -8,235.4%   
Net profit margin %0.1-21.8 -0.5%  
BALANCE SHEET DATA
Current assets Rs m6,8523,810 179.8%   
Current liabilities Rs m6,7118,365 80.2%   
Net working cap to sales %3.3-88.4 -3.8%  
Current ratio x1.00.5 224.2%  
Inventory Days Days161156 103.3%  
Debtors Days Days31867 473.7%  
Net fixed assets Rs m3,67314,480 25.4%   
Share capital Rs m31761 516.5%   
"Free" reserves Rs m3,761903 416.5%   
Net worth Rs m4,0785,127 79.5%   
Long term debt Rs m1,6715,832 28.7%   
Total assets Rs m12,63319,433 65.0%  
Interest coverage x1.0-0.9 -112.3%   
Debt to equity ratio x0.41.1 36.0%  
Sales to assets ratio x0.30.3 125.7%   
Return on assets %3.42.0 175.3%  
Return on equity %0.1-21.9 -0.5%  
Return on capital %7.73.6 211.0%  
Exports to sales %22.924.5 93.4%   
Imports to sales %14.310.2 140.4%   
Exports (fob) Rs m9641,264 76.3%   
Imports (cif) Rs m602525 114.7%   
Fx inflow Rs m9641,539 62.6%   
Fx outflow Rs m607942 64.4%   
Net fx Rs m357597 59.8%   
CASH FLOW
From Operations Rs m1,345599 224.4%  
From Investments Rs m-2,256-438 515.1%  
From Financial Activity Rs m-1,200-303 396.5%  
Net Cashflow Rs m-2,111-141 1,493.8%  

Share Holding

Indian Promoters % 4.5 74.5 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 1.4 1.3 103.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.6 398.7%  
Shareholders   20,807 10,259 202.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NOVARTIS  ASTRAZENECA PHARMA  BIOCON LTD  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - GLENMARK PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS